Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 28, 2008; 14(32): 5025-5031
Published online Aug 28, 2008. doi: 10.3748/wjg.14.5025
Published online Aug 28, 2008. doi: 10.3748/wjg.14.5025
Treatment groups | IP injection | Mouse with tumour | Percentage expression (%) |
Negative control (Hepatocyte only) | 5 x 106 hepatocytes | 0/3 | 0 |
Positive control 1 (HT-29 only) | 5000 HT-29 cells | 0/3 | 0 |
100 000 HT-29 cells | 1/31 | 01 | |
500 000 HT-29 cells | 2/3 | 67 | |
2 million HT-29 cells | 3/3 | 100 | |
Positive control 2 (Hepatocytes + HT-29) | 5 million hepatocytes + 5000 HT-29 | 0/3 | 0 |
5 million hepatocytes + 100 000 HT-29 | 0/3 | 0 | |
5 million hepatocytes + 500 000 HT-29 | 3/3 | 100 | |
5 million hepatocytes + 2 million HT-29 | 2/3 | 67 | |
Bead (Hepatocyte + HT-29) | 5 million hepatocytes + 5000 HT-29 | 0/3 | 0 |
5 million hepatocytes + 100 000 HT-29 | 0/3 | 0 | |
5 million hepatocytes + 500 000 HT-29 | 0/3 | 0 | |
5 million hepatocytes + 2 million HT-29 | 0/3 | 0 |
- Citation: Gunasegaram A, Akhter J, Yao P, Johnson LA, Riodan SM, Morris DL. Hepatocytes isolated from neoplastic liver-immunomagnetic purging as a new source for transplantation. World J Gastroenterol 2008; 14(32): 5025-5031
- URL: https://www.wjgnet.com/1007-9327/full/v14/i32/5025.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.5025